Table 1 Patient Demographics
Variable | Value |
|---|---|
Age (y), median (range) | 61(25–72) |
Gender, n(%) | |
Male | 54(81.8%) |
Female | 12(18.2%) |
Etiology, n(%) | |
HBV | 50(75.8%) |
HCV | 6(9.1%) |
HBV + HCV | 5(7.6%) |
Alcohol | 3(4.5%) |
Others | 2(3%) |
Child-Pugh class, n(%) | |
A | 49(74.2%) |
B | 17(25.8%) |
BCLC class, n(%) | |
A | 45(68.2%) |
B | 21(31.8%) |
MELD, median (range), n(%) | 9.7 ± 3.0/9.0(6.0–19.0) |
Within Milan criteria, n(%) | 40(60.6%) |
Total bilirubin (mg/dL), median (range) | 1.2(0.3–8.8) |
albumin(g/dL), median (range) | 3.4(1.6–4.5) |
INR (sec), median (range) | 1.1(1.0–1.6) |
ALT(U/L), median (range) | 57.0(12.0–400.0) |
Serum creatinine (mg/dL), median (range) | 0.79(0.47–1.37) |
AFP (ng/mL), median (range) | 13.7(2.3–4225.5) |
Time on transplant list (day), median (range) | 97(31–509) |
Time from first TACE to transplantant (day), median (range) | 83(30–582) |
TACE accomplished, Total no. (mean ± SD; range) | 89(1.35 ± 0.67; 1–4) |
Repeat TACE, n(%) | 18(27.3%) |